Molecular profile
- Classification
- Synthetic small-molecule ERR agonist
- Molecular Formula
- C 18 H 14 N 2 O 2
Non-peptide compound reference
SLU-PP-332
SLU-PP-332 is a synthetic research compound studied for its ability to activate estrogen-related receptor alpha (ERRα), a nuclear receptor involved in mitochondrial biogenesis, fatty acid oxidation, and oxidative metabolism. In preclinical models, it has been investigated as an "exercise mimetic" because it appears to reproduce some of the metabolic adaptations normally associated with endurance training, including increased…
Dosing literacy
Dosing & scaling, explained
No mass-based amount example with adequate calculation context is available for this compound. This is educational source context—not a protocol or recommendation.
Calculation context
No source-supported amount ladder is shown
Enter a target amount only from your own reviewed source. The calculator can convert it into concentration, volume and device markings, but it will not infer an amount from product availability or another compound.
Only mcg or mg amounts are retained. The calculator derives mL, syringe units or pen clicks from the current vial strength, water volume and device.
Schedule literacy
No independently verified schedule
Evidence context
No clinical amount or schedule is inferred from this material. Source verification is pending, and every displayed amount remains educational context rather than guidance.
Research best practices
Storage, handling and interpretation
Product identity
Verify the exact compound, formulation and amount against the product label or certificate before calculation.
Storage & handling
Follow the product label, certificate and validated laboratory SOP; no universal storage assumption is applied here.
Prepared solutions
Label concentration and preparation date, use sterile technique where applicable, and follow a validated stability protocol.
Mechanism map
How SLU-PP-332 is being studied to work
This process map organizes available educational context. Individual claims remain subject to source-level verification.
- 01
Process stage
Mechanism of Action
How SLU-PP-332 is thought to mimic parts of the exercise response
- Activates ERRα-related transcriptional programs
- Associated with increased PGC-1α signaling
- Supports mitochondrial biogenesis and respiration research
- Promotes fatty acid oxidation and energy expenditure pathways
Research orientation
What researchers are exploring
These themes organize the educational information currently available. Individual claims remain under source review and are not treatment claims.
- 01
Mechanism of Action
How SLU-PP-332 is thought to mimic parts of the exercise response
- 02
Preclinical Metabolic Research
Findings from obesity, glucose control, and fat metabolism models
- 03
Mitochondrial Function, Endurance & Exercise Mimicry
Why SLU-PP-332 is often described as an exercise mimetic
- 04
Cardiometabolic and Organ Research
Potential relevance to heart, liver, kidney, and brown adipose tissue research
Evidence map
What is known—and what still needs verification
Available context is organized without assigning unsupported study models or evidence grades.
- Source review pending
Research Status & Administration Notes
Important context about current evidence and why no dosing guide is presented
- Source review pending
Mechanism of Action
How SLU-PP-332 is thought to mimic parts of the exercise response
- Source review pending
Preclinical Metabolic Research
Findings from obesity, glucose control, and fat metabolism models
- Source review pending
Mitochondrial Function, Endurance & Exercise Mimicry
Why SLU-PP-332 is often described as an exercise mimetic
Technical reference
Identity, limitations and unknowns
Important limitations
- Safety Concerns & Translational Barriers: What still limits translation from animal research to human use
- Future Research: Where the field is likely heading next